NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ:UNCY) and certain officers. The class action, filed in the United States District Court Northern District of California, and docketed under 25-cv-06923, is on […]
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE:BHVN) and certain officers. The class action, filed in the United States District Court for the District of Connecticut, and docketed under 25-cv-01120, is on
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
Scottsdale, AZ, Sept. 12, 2025 (GLOBE NEWSWIRE) — Today, PXG(R) introduced its 2025 Fall Winter Apparel Collection, a bold reimagining of golf fashion through the lens of utility and uniform. Designed to transition seamlessly from the golf course to everyday life, the collection delivers modern silhouettes, custom prints, technical fabrics, and purposeful details that embody
PXG Unveils 2025 Fall Winter Apparel Collection Utility, Uniform, and Unapologetic Style Define the Season GlobeNewswire September 12, 2025 Scottsdale, AZ, Sept. 12, 2025 (GLOBE NEWSWIRE) — Today, PXG(R) introduced its 2025 Fall Winter Apparel Collection, a bold reimagining of golf fashion through the lens of utility and uniform. Designed to transition seamlessly from the
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeoGenomics and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ:SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sensus and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lesaka Technologies, Inc. ("Lesaka" or the "Company") (NASDAQ:LSAK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lesaka and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / September 12, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=166967&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / September 12, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=166966&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call